Alert

On December 10, Toronto Public Heath declared a Norovirus outbreak on the Complex Continuing Care unit. Other units and programs are operating as usual. Click for more info.

Please note our ambulatory care services will be closed on Dec. 25-26, 2025, and Jan. 1, 2026. The day program will be closed Dec. 22-26, 2025.

#cc0033
Print

A Phase III, Randomized, Double-blind, Placebo-controlled, Efficacy, and Safety Study of Balovaptan in Adults with Autism Spectrum Disorder with a 2-year Open-Label Extension

Medication Clinical Trials

Summary

Please see attached flyer for further details about this study.

Researcher(s)

Evdokia Anagnostou, MD, Melanie Penner MD FRCP(C)

 

Interested in participating

Please note that recruitment is closed at this time. To learn more about this study, you can also contact our study coordinator, Rianne Hastie Adams at email: rhastieadams@hollandbloorview.ca or telephone: 416-425-6220, x6515.

Funding Agency

F. Hoffman-La Roche.

Download Flyer

pdf-iconAdults with Autism see, hear and feel the world in a unique way
Learn more about this study